Novartis To Beef Up Heart Disease Offering With $3 Billion Blackstone-Backed Anthos Therapeutics Deal Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Anthos Therapeutics is a clinical-stage biopharmaceutical company developing abelacimab, a potential first-in-class monoclonal antibody targeting the FXI inhibition pathwayAbelacimab is currently ...

Nvidia stock has been hotter than a graphics card running Call of Duty at max settings. With AI, gaming and data centers fueling its meteoric rise, the chip giant has become one of Wall Street’s ...

Aljamain Sterling is considering his options following his loss at UFC 310.

After hours: 7:59:56 p.m. EST ...

Pre-market: 4:04:25 am GMT-5 ...

After hours: 7:45:02 pm GMT-5 ...